Add listing
    0
    Add listing

    Valerius Biopharma AG Verified listing

    • Swiss Biotech Association
      Not a member

    Valerius Biopharma AG develop biosimilar drugs for therapeutic indications with high medical need. The product pipeline consists of four orphan and non-orphan biosimilar drugs that will be developed according to highest regulatory standards to enable global access for patients at affordable prices.

    Location
    Facts & figures
    • Type of organization
      Private company
    • Year of foundation
      2017
    • Number of employees in Switzerland
      1-9
    Key business

    You may also be interested in